Interim analysis
Interim analysis is a statistical procedure that is used in clinical trials to analyze the data before the trial is completed. This is done to determine if the trial should be stopped early due to safety concerns, efficacy, or futility.
Overview[edit | edit source]
In clinical research, interim analysis is a planned analysis of data collected from participants before the study is completed. The main purpose of interim analysis is to ensure the safety of the participants and to assess the progress of the trial. It can also be used to determine if the trial should be stopped early due to safety concerns, efficacy, or futility.
Purpose[edit | edit source]
The primary purpose of interim analysis is to protect the patient's safety. If the interim analysis shows that the treatment is not effective or is causing harm, the trial can be stopped early to prevent further harm to the participants.
Interim analysis can also be used to determine if the trial is likely to show a significant result if it continues to the end. If the interim analysis shows that the trial is unlikely to show a significant result, the trial can be stopped early to save resources.
Procedure[edit | edit source]
Interim analysis is usually performed by a Data Monitoring Committee (DMC) or a similar independent group. The DMC reviews the data collected from the trial and makes recommendations based on their analysis. The DMC can recommend that the trial continue as planned, be modified, or be stopped early.
Limitations[edit | edit source]
While interim analysis can provide valuable information, it also has some limitations. One limitation is that it can increase the chance of a Type I error, which is the incorrect rejection of a true null hypothesis. To control for this, statistical methods such as the O'Brien-Fleming method or the Pocock method can be used.
Another limitation is that interim analysis can lead to bias if the results are shared with the trial investigators or participants. To prevent this, the results of the interim analysis are usually kept confidential and are only shared with the DMC.
See also[edit | edit source]
References[edit | edit source]
| Interim analysis Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
